Find investors
← Back to all investors
Len Chersky
ResearchedAngel Investors

Len Chersky

Managing Partner, Private Equity

Angel InvestorsSeed Round
Pitch Len

Get their honest, personalized take on your startup.

Sign in to pitch Len

At a glance

Full Name
Len Chersky
Title
Managing Partner, Private Equity
Firm
Brookfield
Firm Type
Global alternative asset manager; private equity platform
Investment Stage
Control or significant-influence private equity investments, buyouts, corporate carve-outs, and large-scale non-control capital through Brookfield Special Investments
Target Company Profile
Leading providers of essential products and services with defensible market positions, durable cash flows, recurring revenue, and room for operational improvement
Sector Focus
Industrials, essential business services, financial infrastructure, healthcare, technology services
Geographic Focus
Asia Pacific, with Brookfield’s broader private equity platform investing globally
Location
Sydney, New South Wales, Australia

Background

Len Chersky is a Managing Partner in Brookfield’s Private Equity Group. Brookfield’s leadership page says he is responsible for investment origination, analysis, and execution in the Asia Pacific region. Sydney Children’s Hospitals Foundation describes his remit as overseeing Brookfield’s private equity business and portfolio companies in Asia Pacific.

Before Brookfield, Chersky was Executive Director at Lend Lease Corporation. Brookfield says he joined in 2014; Sydney Children’s Hospitals Foundation’s profile says he joined in 2013 and has more than 25 years of commercial and investment experience. Earlier in his career, he held senior roles in investment management, financial services, and major listed Australian organizations.

Chersky holds Bachelor of Science and Bachelor of Law degrees from the University of New South Wales. Sydney Children’s Hospitals Foundation specifies that his B.Sc. was in Mathematics. He was appointed Chair of Sydney Children’s Hospitals Foundation in August 2022.

Investment Thesis & Focus

  • Brookfield’s private equity strategy is not seed or angel investing. It is focused on acquiring and operating established businesses at scale.
  • Brookfield describes its private equity platform as acquiring “leading providers of essential products and services” and creating value through “operational transformation.”
  • The firm says it is “focused on delivering operational transformation in industrials and essential business services.”
  • Brookfield’s 2025 private equity outlook emphasizes operational expertise over financial engineering, with value creation focused on commercial strategy, organizational structure, and manufacturing operations.
  • Brookfield says attractive targets include companies selling essential products and services, holding dominant market share, generating recurring revenue, and offering room for efficiency improvement.
  • In Asia Pacific, Brookfield says it is seeing buyout opportunities in pan-Asia businesses seeking capital, operational expertise, stronger executive teams, and best-practice implementation.
  • Brookfield Special Investments can provide large-scale non-control capital, including debt, hybrid capital, or minority equity.

Notable Investments

  • Healthscope: Brookfield Business Partners agreed in January 2019 to acquire Healthscope for approximately A$5.7 billion. Chersky was quoted in the announcement, describing Healthscope as a leading provider of essential healthcare services in Australia and New Zealand.
  • Panthera Finance: In October 2022, Brookfield Special Investments provided a A$150 million senior secured debt facility to the Queensland-based purchased-debt-ledger and credit management company. Chersky called it Brookfield Special Investments’ first investment in Australia.
  • Everise: Brookfield lists Everise as a portfolio highlight in essential services; it is a customer-experience outsourcing business serving healthcare and technology clients.
  • Clarios: Brookfield acquired Clarios in 2019 as a corporate carve-out; Brookfield describes it as the global leader in advanced low-voltage batteries.
  • CDK Global: Brookfield lists CDK Global as an essential-services portfolio company providing mission-critical software for automotive dealers.
  • Chemelex: Brookfield acquired Chemelex in 2025 as a carve-out from an industrial conglomerate; the company makes electric heat-tracing systems.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.